Serologicals Plans Midwest Plant

Published September 2002

ATLANTA -

Serologicals Corp. of Atlanta will decide the location of a second Ex-Cyte manufacturing facility by November 30. Several locations in the Midwest are being considered as the site of the $28-million plant. Completion is slated for the first half of 2004, with a 15 to 18 month construction period.

Serologicals provides biological products and technologies for the research, development, and manufacture of biologically-based life science products.

 

 

 

Copyright 2008 Tradeline Inc.
All Rights Reserved
ISSN: 1096-4894